Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2025-12-24 @ 2:19 PM
NCT ID:
NCT02415595
Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.
Inclusion Criteria:
* Men and non-pregnant women, at least 18 years of age
* Antiretroviral treatment-naïve; defined as no current or previous exposure to \> 1 week of an antiretroviral drug
* Plasma HIV-1 RNA ≥ 1000 copies/mL
* CD4 T-cell count \> 200 cells/mm3
Exclusion Criteria:
* Resistance or partial resistance to any study drug determined by tests at Screening
* Current or historical genotypic and/or phenotypic drug resistance testing showing certain resistance mutations to EFV, TDF, FTC, Protease Inhibitors
* Chronic hepatitis B virus (HBV)/ hepatitis C virus (HCV)
* Blood tests that indicate normal liver function
* Hemoglobin \< 8.0 g/dL, platelets \< 50,000 cells/mm3
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02415595
Study Brief:
Protocol Section:
NCT02415595